Debunking The Detox Myth A group of over 300 young UK scientists and engineers who investigated the evidence behind claims made for products and diets, have started a public awareness campaign by publishing a dossier that shows the word "detox" has no meaning outside of the clinical treatment of drug addiction and poisoning. Called the "Detox Dossier", the report describes the findings of the investigation by the Voice of Young Science (VoYS) network of over 300 early career researchers.
A Rigorous Method For Liver BiopsyLiver biopsy is still considered the gold standard for grading, staging and "stad-ging" the chronic liver disease. In addition, it remains a primary source for acquiring new knowledge on the liver pathology.
Molecular Events Involved In Liver Regeneration The ability to regenerate after major tissue damage or surgical intervention is an important property of the liver. Since liver resection is an established therapeutic measure for severe liver diseases, it would be of importance to know which molecular events underly the regenerative process and if they depend on the extent of resection, as indicated in previous studies. The group led by Prof.
Molecular Events Involved In Liver Regeneration The ability to regenerate after major tissue damage or surgical intervention is an important property of the liver. Since liver resection is an established therapeutic measure for severe liver diseases, it would be of importance to know which molecular events underly the regenerative process and if they depend on the extent of resection, as indicated in previous studies. The group led by Prof.
Liver Cancer Hope - Acculis Microwave Tissue Ablation System Worldwide Launch Extended In Europe, The Americas And AsiaAcculis Limited, the leading UK microwave ablation system company, today announced the extension of the worldwide launch of their pioneering Microwave Tissue Ablation (MTA) system for the coagulation of soft tissue in open surgery. The system is being used by the world's best liver surgeons to treat liver cancers. MTA is the only FDA 510(k) cleared single needle high power 2.45GHz microwave system. It achieves 5cm x 6.5cm coagulations with single 8 minute applications and 4.
Math Patterns Show Who Will Respond To Hep C TreatmentGenetic patterns are like the tea leaves in the bottom of a cup for predicting which patients are likely to respond to medical therapy for life-threatening viruses such as hepatitis C, Saint Louis University researchers have discovered. Their findings are published in the Dec. 22 early online issue of the Journal of Clinical Investigation.
FDA Clears Covidien's Evident™ Microwave Ablation System For Use In Nonresectable Liver Tumor AblationCovidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products , today announced that the United States Food and Drug Administration (FDA) has issued a 510(k) marketing clearance for the Evident™ Microwave (MW) Ablation System, intended for use in the ablation of nonresectable liver tumors. This new system offers a procedural option for patients who are not candidates for surgical resection and have few remaining treatment options.
Sorafenib Is Effective In Asian-Pacific Patients With Advanced Liver Cancer Sorafenib significantly increases overall survival in Asian-Pacific patients with advanced hepatocellular carcinoma - a group where surgical treatments can be limited - according to findings of a phase III trial reported in an Article published early Online and in the January edition of The Lancet Oncology. Hepatocellular carcinoma is the third most common cause of cancer-related death and is a particular challenge in the Asia-Pacific region, where 75% of cases occur.